(Q51317864)

3 April 2018

title

Adaptive Aerosol Delivery (AAD) technology. (English)

1 reference

3 April 2018

author name string

Denyer J

series ordinal

1

1 reference

3 April 2018

Nikander K

series ordinal

2

1 reference

3 April 2018

Smith NJ

series ordinal

3

1 reference

3 April 2018

language of work or name

English

0 references

publication date

1 November 2004

1 reference

3 April 2018

Expert Opinion on Drug Delivery

published in

1 reference

3 April 2018

volume

1

1 reference

3 April 2018

issue

1

1 reference

3 April 2018

page(s)

165-176

1 reference

3 April 2018

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

1 reference

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

Drug delivery and adherence in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

Parents' Adherence with Nebulizer Treatment of Their Children When Using an Adaptive Aerosol Delivery (AAD™) System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.1.1.165

21 January 2018

Identifiers

DOI

10.1517/17425247.1.1.165

1 reference

3 April 2018

PubMed ID

16296727

1 reference

3 April 2018